Atara Biotherapeutics to Present Phase 1 Study Update of ATA188 in Progressive Multiple Sclerosis at ECTRIMS 2021
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com
Stay updated with breaking news from Douglasl Arnold. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Business Wire. The AP news staff was not involved in its creation.